Welsis (WLSS) EBIT Margin (2022 - 2023)
Welsis (WLSS) posted EBIT Margin of 613.25% for Q4 2023, down 22277.28% on a QoQ basis from 2.77% in Q3 2023, and down 35008.0% year-over-year from N/an in Q4 2022.
Powered by 
Analysis
Welsis (WLSS) EBIT Margin (2022 - 2023) Analysis & Trends
Welsis has reported EBIT Margin for 2 years, with the latest figure at 613.25% in Q4 2023.
- On a quarterly basis, EBIT Margin fell 35008.0% year-over-year to 613.25% in Q4 2023; TTM through Sep 2024 was 2894.9%, a 277170.0% decrease from a year earlier, with the FY2024 full-year figure at 2894.9%, down 277493.0% from the prior year.
- EBIT Margin was 613.25% for Q4 2023 at Welsis, down from 2.77% in the prior quarter.
- The five-year high for EBIT Margin was 2.77% in Q3 2023, with the low at 613.25% in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Hinge Health | 7.41 Bn | 7.03 Bn | 183.95 Mn | 19.00% |
| 2 | Hims & Hers Health | 6.47 Bn | 5.63 Bn | 480.80 Mn | -12.90% |
| 3 | Ethos Technologies | 2.54 Bn | 2.37 Bn | 185.54 Mn | 9.56% |
| 4 | Omada Health | 1.38 Bn | 1.16 Bn | 63.79 Mn | 4.04% |
| 5 | Teladoc Health | 1.14 Bn | 366.41 Mn | 416.09 Mn | -6.11% |
| 6 | Talkspace | 870.58 Mn | 779.48 Mn | 24.80 Mn | -3.43% |
| 7 | Akso Health | 259.44 Mn | 259.25 Mn | - | - |
| 8 | LifeMD | 147.29 Mn | 147.29 Mn | - | - |
| 9 | eHealth | 31.71 Mn | -69.34 Mn | - | -81.80% |
| 10 | Welsis | 1.65 Mn | 1.65 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -613.25% |
| Sep 30, 2023 | 2.77% |
| Jun 30, 2023 | -60.64% |
| Dec 31, 2022 | -263.17% |